Clincosm LogoSign in Get a demo

HER2-negative Breast Cancer

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

HER2-negative Breast Cancer, Advanced Breast Cancer Trial in Guangzhou (Organoid-guided treatment, Taxane, Capecitabine)

Not yet recruiting
  • HER2-negative Breast Cancer
  • Advanced Breast Cancer
  • Organoid-guided treatment
  • +5 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 22, 2023

Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

Active, not recruiting
  • Hormone-receptor-positive Breast Cancer
  • +2 more
  • No drug
  • Cambridge, Massachusetts
    ConcertAI database
Sep 8, 2023

Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Dapagliflozin 10mg
  • New Haven, Connecticut
    Yale Cancer Center Smilow Cancer Hospital
Aug 3, 2023

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

HER2-negative Breast Cancer Trial in Budapest (device, drug, procedure)

Recruiting
  • HER2-negative Breast Cancer
  • Oncotherm EHY-2030
  • +4 more
  • Budapest, Hungary
    Division of Oncology, Department of Internal Medicine and Oncolo
May 25, 2023

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

    Recruiting
    • HER2-positive Breast Cancer
    • +17 more
    • ALX148
    • Fam-Trastuzumab Deruxtecan-Nxki
    • Chicago, Illinois
    • +1 more
    May 19, 2023

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

    Not yet recruiting
    • PIK3CA Mutation
    • +7 more
    • (no location specified)
    Mar 7, 2023

    Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

    Recruiting
    • Ovarian Cancer
    • +8 more
    • Scottsdale, Arizona
    • +11 more
    Jan 31, 2023

    Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

    Recruiting
    • Breast Neoplasms
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Jan 30, 2023

    HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

    Recruiting
    • HER2-negative Breast Cancer
    • Batumi, Georgia
    • +18 more
    Jan 13, 2023

    Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

    Not yet recruiting
    • Colorectal Cancer
    • +8 more
    • (no location specified)
    Jan 5, 2023

    HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma Trial in Houston (L-NMMA)

    Recruiting
    • HER2-negative Breast Cancer
    • +3 more
    • Houston, Texas
      Houston Methodist Neal Cancer Center
    Jan 12, 2023

    Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

    Recruiting
    • Triple Negative Breast Cancer
    • HER2-negative Breast Cancer
    • HER2 - primed Dendritic cells
    • HER3 - primed Dendritic cells
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 10, 2023

    Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

    Recruiting
    • Breast Neoplasm
    • +4 more
    • PIK3CA inhibitor
    • +12 more
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jan 2, 2023

    Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Ovarian function suppression with endocrine treatments
    • Seoul, Korea, Korea, Republic of
      Gangnam Severance Hospital
    Dec 18, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 16, 2022

    Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab

    Recruiting
    • Invasive Breast Cancer
    • +3 more
    • Atlanta, Georgia
    • +7 more
    Nov 14, 2022

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    HER2-negative Breast Cancer, Triple Negative Breast Cancer Trial in France, Germany, Ireland (Capecitabine, Carboplatin,

    Recruiting
    • HER2-negative Breast Cancer
    • Triple Negative Breast Cancer
    • Brasschaat, Belgium
    • +161 more
    Nov 2, 2022